Coalition letter to House Judiciary Committee urging support of the CBM Review Program
Issue Date: November 19, 2013
US HR 3309 - Innovation Act
NAR, in coalition with other industry groups, sent a letter to the House Judiciary Committee urgings its members to reject any amendments to Chairman Goodlatte's (R-VA) bipartisan "Innovation Act" (H.R. 3309) which would strip the "Covered Business Method (CBM) Patent Reviews" from the bill.